The BMCS Mastering MedChem VIII: 8th RSC-BMCS Symposium on Mastering Medicinal Chemistry

The BMCS Mastering MedChem VIII: 8th RSC-BMCS Symposium on Mastering Medicinal Chemistry

Friday 15th March 2024

Burlington House, London

Important links and downloads
X hashtag – #MasteringMedChem24
To download the first announcement poster, click here
To download the second announcement poster, click here

Mastering Medicinal Chemistry VIII is the latest in an ongoing series of conferences intended to provide expert advice and guidance to new practitioners in the field of drug discovery. It has been said that “there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems”. Anticipating and preparing for such problems thus accelerates the delivery of new medicines: this event will feature presentations from experienced ‘drug-hunters’ in both industry and academia, who will talk about the challenges faced in modern drug discovery, and will share best practice common to all successful medicinal chemists.

The RSC-BMCS are offering a small number of bursaries to attend the meeting in person. Applications are open to PhD and post-doctoral applicants studying at academic institutions or non-profit institutions. Preference will be given to members of the RSC-BMCS. Bursary applications are also invited from RSC or EFMC members who are of working age, but currently unemployed, and from those who may have difficulty in funding themselves or whose organisations may have difficulty in funding their attendance. The bursary value for this event is up to £350 and applicants have to fill an RSC-BMCS application form.

Bursary applications are now closed.

Registration has now closed.

RSC Member Early bird £130
Non-Member Early bird £160
RSC Student Member Early bird £67
Student Non-Member Early bird £82

Early bird registration closed Midnight (GMT) Friday 12th January, 2024

RSC Member £155
Non-Member £190
RSC Student Member £80
Student Non-Member £91

Registration closed Midnight (GMT) Sunday 10th March, 2024

Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC, please follow this RSC link.

Sponsorship/Exhibition Opportunities
Bookings to sponsor or exhibit at the meeting have now closed.

Exhibition Package includes:
– One stand personnel with access to technical sessions
– A six-foot trestle table and chair(s)
– Electrical and Wi-Fi access
– Your logo and full promotional page in the pdf of the delegate handbook
– Your logo in the rolling slides, shown during the breaks
– Any additional stand personnel will have to be booked as delegates

Sponsorship of lanyards
All delegates will be given a lanyard to hold their name badge on arrival. The delegates will be given lanyards with your company’s logo on arrival Sponsoring the lanyards will ensure that delegates have your company name on them at all times and will therefore provide a high profile throughout the duration of the conference. Your company logo and website link will also be displayed on the conference website.

We are also seeking sponsorship from organisations supporting the low registration fees offered to students.

Sponsorship includes
-Your logo in the pre-event announcements
-Your logo in the pdf of the delegate handbook
-Your logo in the rolling slides, shown during the breaks
-Your logo included in the communication email to delegates


09:40Registration and refreshments
10:10Opening remarks
Asier Unciti-Broceta, University of Edinburgh
Session Chair: A. Ganesan, University of East Anglia
10.15Leveraging medicinal chemistry to develop sustainable drugs
Maria Laura Bolognesi, Universita di Bologna, Italy
11.00What a medicinal chemist needs to know about CNS drug discovery
Nadia Ahmad, Charles River Laboratories
11.45Novel inhibitors of efflux pump NorA to target antimicrobial resistance
Janine Gray, Imperial College London
11.52Development of Cleavable Linkers for Polymer-Drug Conjugates
Sarah Phillips, University of Cambridge
11.59Design, Synthesis, and In Vitro Characterisation of Activin Receptor-like Kinase 2 Degraders as a Novel Therapeutic Strategy Towards the Treatment of Diffuse Intrinsic Pontine Glioma
Daniel Webb, University of Strathclyde
12.06Assessment of the Bioorthogonality of the Nitrile Imine 1,3-Dipole
Mhairi Gibson, University of Strathclyde
12.15Lunch, exhibition and poster session
Session Chair: Andrew Stachulski, University of Liverpool
13.15Mitigating Metabolism-dependent toxicity in preclinical drug discovery/development
Amit Kalgutkar, Pfizer
14.00Selective Estrogen Receptor Degraders (SERDs): Failure, Success and Lessons Learned
Jamie Scott, AstraZeneca
14.45Refreshments, exhibition and posters
Session Chair: Helen Aylott, Redx Pharma
15.15Next generation utrophin modulators for Duchenne muscular dystrophy: learning from clinical set backs
Angela Russell, University of Oxford
16.00Understanding chemical space for building block diversity
Francesco Rianjongdee, GSK
16.45Closing remarks
Asier Unciti-Broceta, University of Edinburgh
Drinks reception




Organising Committee
Helen Aylott, Redx Pharma (Treasurer)
Rose Bardell-Cox, Evotec
Arasu Ganesan, University of East Anglia
Andrew Stachulski, University of Liverpool
Asier Unciti-Broceta, University of Edinburgh (Chair)

Secretariat Contact
Hg3 Conferences Ltd
+44 (0)1423 529333